Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1998 2
1999 2
2001 4
2002 12
2003 14
2004 14
2005 14
2006 18
2007 8
2008 3
2009 6
2010 3
2011 4
2012 2
2013 2
2014 3
2015 2
2016 5
2017 3
2018 6
2019 4
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Results by year
Filters applied: . Clear all
Page 1
Sipa1 deficiency-induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm.
Xiao P, Dolinska M, Sandhow L, Kondo M, Johansson AS, Bouderlique T, Zhao Y, Li X, Dimitriou M, Rassidakis GZ, Hellström-Lindberg E, Minato N, Walfridsson J, Scadden DT, Sigvardsson M, Qian H. Xiao P, et al. Among authors: rassidakis gz. Blood Adv. 2018 Mar 13;2(5):534-548. doi: 10.1182/bloodadvances.2017013599. Blood Adv. 2018. PMID: 29514790 Free PMC article.
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations.
Zerdes I, Matikas A, Bergh J, Rassidakis GZ, Foukakis T. Zerdes I, et al. Among authors: rassidakis gz. Oncogene. 2018 Aug;37(34):4639-4661. doi: 10.1038/s41388-018-0303-3. Epub 2018 May 16. Oncogene. 2018. PMID: 29765155 Free PMC article. Review.
STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer.
Zerdes I, Wallerius M, Sifakis EG, Wallmann T, Betts S, Bartish M, Tsesmetzis N, Tobin NP, Coucoravas C, Bergh J, Rassidakis GZ, Rolny C, Foukakis T. Zerdes I, et al. Among authors: rassidakis gz. Cancers (Basel). 2019 Oct 1;11(10):1479. doi: 10.3390/cancers11101479. Cancers (Basel). 2019. PMID: 31581535 Free PMC article.
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.
Xu-Monette ZY, Xiao M, Au Q, Padmanabhan R, Xu B, Hoe N, Rodríguez-Perales S, Torres-Ruiz R, Manyam GC, Visco C, Miao Y, Tan X, Zhang H, Tzankov A, Wang J, Dybkær K, Tam W, You H, Bhagat G, Hsi ED, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, van Krieken JH, Winter JN, Westin JR, Pham LV, Medeiros LJ, Rassidakis GZ, Li Y, Freeman GJ, Young KH. Xu-Monette ZY, et al. Among authors: rassidakis gz. Cancer Immunol Res. 2019 Apr;7(4):644-657. doi: 10.1158/2326-6066.CIR-18-0439. Epub 2019 Feb 11. Cancer Immunol Res. 2019. PMID: 30745366 Free article. Clinical Trial.
Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens.
Rassidakis GZ, Herold N, Myrberg IH, Tsesmetzis N, Rudd SG, Henter JI, Schaller T, Ng SB, Chng WJ, Yan B, Ng CH, Ravandi F, Andreeff M, Kantarjian HM, Medeiros LJ, Xagoraris I, Khoury JD. Rassidakis GZ, et al. Blood Cancer J. 2018 Oct 19;8(11):98. doi: 10.1038/s41408-018-0134-z. Blood Cancer J. 2018. PMID: 30341277 Free PMC article.
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.
Li L, Sun R, Miao Y, Tran T, Adams L, Roscoe N, Xu B, Manyam GC, Tan X, Zhang H, Xiao M, Tzankov A, Visco C, Dybkaer K, Bhagat G, Tam W, Hsi ED, van Krieken JH, You H, Huh J, Ponzoni M, Ferreri AJM, Møller MB, Piris MA, Zhang M, Winter JN, Medeiros LJ, Rassidakis GZ, Vaupel CA, Li Y, Dakappagari N, Xu-Monette ZY, Young KH. Li L, et al. Among authors: rassidakis gz. Mod Pathol. 2019 Jun;32(6):741-754. doi: 10.1038/s41379-018-0193-5. Epub 2019 Jan 21. Mod Pathol. 2019. PMID: 30666052 Free article.
Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.
Rudd SG, Tsesmetzis N, Sanjiv K, Paulin CB, Sandhow L, Kutzner J, Hed Myrberg I, Bunten SS, Axelsson H, Zhang SM, Rasti A, Mäkelä P, Coggins SA, Tao S, Suman S, Branca RM, Mermelekas G, Wiita E, Lee S, Walfridsson J, Schinazi RF, Kim B, Lehtiö J, Rassidakis GZ, Pokrovskaja Tamm K, Warpman-Berglund U, Heyman M, Grandér D, Lehmann S, Lundbäck T, Qian H, Henter JI, Schaller T, Helleday T, Herold N. Rudd SG, et al. Among authors: rassidakis gz. EMBO Mol Med. 2020 Mar 6;12(3):e10419. doi: 10.15252/emmm.201910419. Epub 2020 Jan 17. EMBO Mol Med. 2020. PMID: 31950591 Free PMC article.
Deciphering lymphoma pathogenesis via state-of-the-art mass spectrometry-based quantitative proteomics.
Psatha K, Kollipara L, Voutyraki C, Divanach P, Sickmann A, Rassidakis GZ, Drakos E, Aivaliotis M. Psatha K, et al. Among authors: rassidakis gz. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Mar 15;1047:2-14. doi: 10.1016/j.jchromb.2016.11.005. Epub 2016 Nov 15. J Chromatogr B Analyt Technol Biomed Life Sci. 2017. PMID: 27979587 Review.
Alterations in the expression of DNA damage response-related molecules in potentially preneoplastic oral epithelial lesions.
Nikitakis NG, Rassidakis GZ, Tasoulas J, Gkouveris I, Kamperos G, Daskalopoulos A, Sklavounou A. Nikitakis NG, et al. Among authors: rassidakis gz. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):637-649. doi: 10.1016/j.oooo.2018.03.006. Epub 2018 Mar 22. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018. PMID: 29705090
127 results
Jump to page
Feedback